Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Podcast: 'Mental health first aid should also be a priority'

Having just completed a mental health first aid adult course, Babir Malik tells C+D about his experience of becoming a mental health first aider

C+D’s clinical and custom content editor, Naimah Callachand, spoke to Babir Malik, community pharmacy foundation lead for Weldricks and teacher practitioner. Mr Malik recently qualified as a mental health first aider, having completed a Mental Health First Aid (MHFA) adult course.

“There are a lot of stigmas attached to mental ill health,” says Mr Malik. “People don’t get adequate treatment or delay accessing treatment.”

The MHFA courses aims to improve the stigma around mental health by encouraging open conversation and signposting those who are struggling to the support they need.

Mr Malik says: “[These courses] are not just aimed at people working in the pharmacy.” Pharmacy team members may also be well placed to identify patients who require mental health support due to “varying levels of stress around the pharmacy”.

“Mental health first aid should also be a priority,” says Mr Malik. “If you can’t access the training via your employer, there are a variety of courses available for a variety of prices.”

You can find more information on MHFA courses on the MHFA England website.

You can listen to the podcast below. Alternatively, follow C+D's podcasts by searching “Chemist+Druggist podcast” on your preferred app or on Soundcloud.

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD005301

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel